Applied Statistics

The preeminence of clusters

Many cities and countries still view the foundation of a biotech sector as desirable for a high-tech, intellectually driven economy. But a discussion by seasoned biotech management and investors suggests that attaining an environment with the right mix of money, management and innovation remains a difficult and long-term challenge.

Location is interwoven with the ability of biotech startups to prosper. Regions with

nascent biotech sectors often find attracting the necessary financial and human resources to

their area an uphill struggle, which can mean the difference between success or failure for a fledgling life science business. In the following article, a group of experienced biotech executives and investors from around the world discuss the pros and cons of building a business inside or

outside a cluster. The article is an abridged transcript of a Bioentrepreneur roundtable discussion

held at the Marriott Boston Copley Place; it was convened at the Biotechnology Industry

Organization International Convention in Boston, May 5, 2007. It has been edited to

address the major themes of that discussion.

Nature Biotechnology


About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.